Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather H Cheng

Showing results (51-60 of 141) with videos related to

Pageof 15
Sort By:
Annals of Surgical Oncology|November 6, 2022
Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate CancersNina M Clark, Emma A Roberts, Catherine Fedorenko, et al.
The Journal of Urology|April 8, 2022
A Patient-Centered Approach to Research Prioritization in Prostate CancerYaw A Nyame, James A Schraidt, Marty Chakoian, et al.
Advances in Urology|January 3, 2014
Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder CancerFranklin C Lee, William Harris, Heather H Cheng, et al.
The Prostate|March 14, 2019
Clinical determinants for successful circulating tumor DNA analysis in prostate cancerMichael T Schweizer, Roman Gulati, Mallory Beightol, et al.
European Urology|January 7, 2023
Genetic Risk Prediction for Prostate Cancer: Implications for Early Detection and PreventionTyler M Seibert, Isla P Garraway, Anna Plym, et al.
Plos One|September 30, 2020
Impact of mutations in homologous recombination repair genes on treatment outcomes for metastatic castration resistant prostate cancerAlexander S Carlson, Rigo I Acevedo, Daniel M Lim, et al.
European Urology Oncology|May 24, 2025
Results from a Phase 2 Study of Induction Docetaxel and Carboplatin Followed by Maintenance Rucaparib in the Treatment of Patients with Metastatic Castration-resistant Prostate Cancer with DNA Homologous Recombination Repair DeficiencyRuben Raychaudhuri, Heather H Cheng, Roman Gulati, et al.
Clinical Genitourinary Cancer|February 25, 2014
Role of maximal endoscopic resection before cystectomy for invasive urothelial bladder cancerAndrew C James, Franklin C Lee, Jason P Izard, et al.
JAMA Oncology|November 5, 2020
Association of Clonal Hematopoiesis in DNA Repair Genes With Prostate Cancer Plasma Cell-free DNA Testing InterferenceKendal Jensen, Eric Q Konnick, Michael T Schweizer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2024
SPECT/CT in Early Response Assessment of Patients with Metastatic Castration-Resistant Prostate Cancer Receiving <sup>177</sup>Lu-PSMA-617Ridvan Arda Demirci, Roman Gulati, Jessica E Hawley, et al.
Pageof 15

Showing results (51-60 of 141) with videos related to

Sort By:
Pageof 15
Annals of Surgical Oncology|November 6, 2022
Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate CancersNina M Clark, Emma A Roberts, Catherine Fedorenko, et al.
The Journal of Urology|April 8, 2022
A Patient-Centered Approach to Research Prioritization in Prostate CancerYaw A Nyame, James A Schraidt, Marty Chakoian, et al.
Advances in Urology|January 3, 2014
Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder CancerFranklin C Lee, William Harris, Heather H Cheng, et al.
The Prostate|March 14, 2019
Clinical determinants for successful circulating tumor DNA analysis in prostate cancerMichael T Schweizer, Roman Gulati, Mallory Beightol, et al.
European Urology|January 7, 2023
Genetic Risk Prediction for Prostate Cancer: Implications for Early Detection and PreventionTyler M Seibert, Isla P Garraway, Anna Plym, et al.
Plos One|September 30, 2020
Impact of mutations in homologous recombination repair genes on treatment outcomes for metastatic castration resistant prostate cancerAlexander S Carlson, Rigo I Acevedo, Daniel M Lim, et al.
European Urology Oncology|May 24, 2025
Results from a Phase 2 Study of Induction Docetaxel and Carboplatin Followed by Maintenance Rucaparib in the Treatment of Patients with Metastatic Castration-resistant Prostate Cancer with DNA Homologous Recombination Repair DeficiencyRuben Raychaudhuri, Heather H Cheng, Roman Gulati, et al.
Clinical Genitourinary Cancer|February 25, 2014
Role of maximal endoscopic resection before cystectomy for invasive urothelial bladder cancerAndrew C James, Franklin C Lee, Jason P Izard, et al.
JAMA Oncology|November 5, 2020
Association of Clonal Hematopoiesis in DNA Repair Genes With Prostate Cancer Plasma Cell-free DNA Testing InterferenceKendal Jensen, Eric Q Konnick, Michael T Schweizer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2024
SPECT/CT in Early Response Assessment of Patients with Metastatic Castration-Resistant Prostate Cancer Receiving <sup>177</sup>Lu-PSMA-617Ridvan Arda Demirci, Roman Gulati, Jessica E Hawley, et al.
Pageof 15